Advances in peritoneal dialysis: a review. - Wikidata - wikimedia - TriplyDB

Advances in peritoneal dialysis: a review.

Advances in peritoneal dialysis: a review.

http://www.wikidata.org/entity/Q38034577

about

Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis Management of a rapidly growing peritoneal dialysis population at the First Affiliated Hospital of Sun Yat-sen University Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.Clinical outcome of home hemodialysis in patients with previous peritoneal dialysis exposure: evaluation of the integrated home dialysis model.Predicting one-year mortality in peritoneal dialysis patients: an analysis of the China Peritoneal Dialysis Registry.Morphological Retrospective Study of Peritoneal Biopsies from Patients with Encapsulating Peritoneal Sclerosis: Underestimated Role of Adipocytes as New Fibroblasts Lineage?Patient-Doctor Contact Interval and Clinical Outcomes in Continuous Ambulatory Peritoneal Dialysis Patients.Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis.Peritoneal Dialysis Fluid and Some of Its Components Potentiate Fibrocyte Differentiation.Implementation of a continuous quality improvement program reduces the occurrence of peritonitis in PD.Rapamycin inhibits epithelial-to-mesenchymal transition of peritoneal mesothelium cells through regulation of Rho GTPases.

P2860

Q33701827-A345F1D7-DEFE-4E7C-BD1D-E14098E088D6 Q33828198-7F08E418-C12D-43B3-9A1E-E2126BC72A7E Q35106053-DF6501CF-F8BA-494C-8BDD-D2C76D94BB5A Q35605375-5A498E3F-936A-401E-AAF6-5F2513B04B64 Q35647453-4FE7153C-826D-4620-9363-F53CB4826206 Q35651140-151AF361-C1E3-4629-9D80-F0BC1EA3E0FD Q36017652-1699D675-8FCD-45EE-AB5D-AD13967A97A4 Q38903043-A3EDE4BB-452F-4B4E-B707-234DD8D858EC Q40974170-BD094D87-CD53-44C5-A70F-692A5625FAC7 Q42430642-04F71E28-AA2F-4239-BDF5-FF465623BD30 Q43464180-8E8B41E7-B7A6-4384-9BA7-E022B51B5D11 Q53119226-1350E62F-8F41-44CB-851E-0C87A504EDE4

P2860

Advances in peritoneal dialysis: a review.

http://www.wikidata.org/entity/Q38034577

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Advances in peritoneal dialysis: a review.

@en

type

label

Advances in peritoneal dialysis: a review.

@en

prefLabel

Advances in peritoneal dialysis: a review.

@en

P1433

Q38034577-7B2F5BCF-E9A5-4681-A53F-4BC941BB5287

P1476

Q38034577-2D8D85F5-AB74-45C2-B02E-0DC73B29B70F

P2093

Q38034577-BCB8A978-161E-4C32-9CB2-DF096CD4D39D

P2860

Q38034577-26295999-6F9B-4256-8860-DB6D64666985

Q38034577-4ED9DEB0-AE45-40B6-A5E0-096AFD6FF1FA

Q38034577-50F0809B-94D2-4666-B6C7-462974B8BC96

Q38034577-55235E3E-F87F-4593-A22D-08226B840DC1

Q38034577-5733B53D-C941-452F-A615-23DD78EA55A5

Q38034577-91A94D3B-8116-4C9B-B494-47A2E7C738B8

Q38034577-96527F1C-AFC6-4099-9447-DCCAEDDBE1FD

Q38034577-A6967065-292A-40B2-A692-2CF3277F33F7

Q38034577-AAD1EED9-1707-4CBB-BAE4-0E9E9A7FC548

Q38034577-BC33AFDA-4973-4213-B42C-786CD4712D8B

P304

Q38034577-3DD8B4CA-96A7-447B-8C40-94299E8B934A

P31

Q38034577-FAF4AF25-08C1-439B-A376-6BAE0E260590

P356

Q38034577-FCB9C13D-E577-4EC3-9C4E-3A7B0CFFF416

P433

Q38034577-7457C587-C20B-4AB4-89CF-37EF3D9042D9

P478

Q38034577-B5A430A2-D472-4849-9882-6497149DDB7C

P577

Q38034577-CDCFF9D4-8BE8-4A24-A1F8-B2D273D4EA1E

P698

Q38034577-3EC4ABFD-3B57-4583-AD22-2ECFDABB1B23

P921

Q38034577-C14521F3-CF53-403A-BE33-6AE60C3A9FF4

P356

J.1525-139X.2012.01124.X

P1433

Seminars in Dialysis

P1476

Advances in peritoneal dialysis: a review.

@en

P2093

Joanne M Bargman

http://www.w3.org/2001/XMLSchema#string

P2860

An update on the comparisons of mortality outcomes of hemodialysis and peritoneal dialysis patients.

Hemodialysis vascular access modifies the association between dialysis modality and survival.

Selection bias explains apparent differential mortality between dialysis modalities.

Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis.

The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.

Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy.

Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.

Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.

Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease.

Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.

P304

545-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1525-139X.2012.01124.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22892042

http://www.w3.org/2001/XMLSchema#string

P921